Rapid Advancements Connected Drug Delivery Devices Market to Fuel Revenues Through 2018-2026

Editorial & Advertiser Disclosure Global Banking And Finance Review is an independent publisher which offers News, information, Analysis, Opinion, Press Releases, Reviews, Research reports covering various economies, industries, products, services and companies. The content available on globalbankingandfinance.com is sourced by a mixture of different methods which is not limited to content produced and supplied by various staff writers, journalists, freelancers, individuals, organizations, companies, PR agencies Sponsored Posts etc. The information available on this website is purely for educational and informational purposes only. We cannot guarantee the accuracy or applicability of any of the information provided at globalbankingandfinance.com with respect to your individual or personal circumstances. Please seek professional advice from a qualified professional before making any financial decisions. Globalbankingandfinance.com also links to various third party websites and we cannot guarantee the accuracy or applicability of the information provided by third party websites. Links from various articles on our site to third party websites are a mixture of non-sponsored links and sponsored links. Only a very small fraction of the links which point to external websites are affiliate links. Some of the links which you may click on our website may link to various products and services from our partners who may compensate us if you buy a service or product or fill a form or install an app. This will not incur additional cost to you. A very few articles on our website are sponsored posts or paid advertorials. These are marked as sponsored posts at the bottom of each post. For avoidance of any doubts and to make it easier for you to differentiate sponsored or non-sponsored articles or links, you may consider all articles on our site or all links to external websites as sponsored . Please note that some of the services or products which we talk about carry a high level of risk and may not be suitable for everyone. These may be complex services or products and we request the readers to consider this purely from an educational standpoint. The information provided on this website is general in nature. Global Banking & Finance Review expressly disclaims any liability without any limitation which may arise directly or indirectly from the use of such information.

Increasing digitalization is anticipated to propel growth in the global connected drug delivery devices market. Fortune Business Insights has recently announced a report, titled “Connected Drug Delivery Devices Market Size, Share and Global Trend By Product Type (Sensors, Integrated devices), Application (Diabetes, Multiple Sclerosis, Asthma and COPD, Hypertension), End Users (Home Care Settings, Hospitals, Surgical Centers) and Geography Forecast till 2026.” Increasing adoption of mobile apps for medical purposes is expected to increase the growth rate in the market.

Browse Complete Report Details @

https://www.fortunebusinessinsights.com/industry-reports/connected-drug-delivery-devices-market-100380

On the basis of region, in 2018 North America held a considerable share in the global market. The region is expected to emerge dominant over the forecast period 2019-2026. Owing to the high presence of key market players, the region is likely to have major gains. Moreover, technological advancements in the drug delivery devices Are anticipated to contribute towards market expansion. Europe is foreseen to be among the leading regions.

The region is witnessing high demand for home treatment. Furthermore, favorable reimbursement policies in the region is a factor expected to drive the market. Besides this, the Asia Pacific connected drug delivery devices market is likely to have major gains. Owing to the high prevalence of the chronic disorder in the region, the market is likely to witness expansion. The increasing healthcare expenditure in the region is further expected to contribute towards the market growth.

Technological Advancements in Devices to Fuel Demand in Market

Factor expected to drive the global market is the advantages of the devices such as reimbursement evidence, better dose measurement, and efficient monitoring of the patient. Moreover, innovation in the connected drug delivery devices is expected to fuel the demand in the market.

In 2018, the U.S. Food and Drug Administration, approved Companion Medical’s new product, InPen. The system includes a special insulin pen-enabled with diabetes management mobile app. Such advancement is expected to contribute towards the market expansion.

Request Sample PDF @

https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/connected-drug-delivery-devices-market-100380

On the flip side, the risk of data privacy associated with devices is a factor that may restrain the global connected drug delivery devices market to a certain extent. Additionally, the high cost associated with these devices is a factor that might hamper the growth in the market.

AptarGroup, Inc., and Propeller Health to Set Higher Standards for Other Players

The U.S. Food and Drug Administration approved AliveCor, Inc.’s new product, cardia and. The devices are enabled with personal electrocardiogram, to detect sinus heart rhythms and atrial fibrillation. Development of new devices is further expected to increase growth in the global connected drug delivery devices market.

The competition among the market players is increasing owing to the prevailing opportunities in the market. Certain players are focusing on product development to attain a higher share in the market. Some players are involved in partnership and mergers and acquisition to attain a strong brand presence.

For instance, AptarGroup, Inc., and Propeller Health partnered together in 2018. The aim of the partnership is to launch a platform to develop digital medicines. Some of the key players operating in the globally connected drug delivery devices market are Propeller Health, Cohero Health Inc., AliveCor, Inc., Teva Pharmaceutical Industries Ltd., Phillips-Medisize, Medtronic, 3M, Proteus Digital Health, Inc., and West Pharmaceutical Services, Inc.

More Trending Topics from Future Business Insights:

Savory Ingredients Market Forecast to Reach US$ 11.94 Billion by 2026, Kerry Group’s Multimillion-Dollar Takeover Will Favor Market Growth, Says Fortune Business Insights

Hot Sauce Market to Reach US$ 3.77 Bn by 2026, Riding High on Rising Demand for International Cuisines, says Fortune Business Insights

About us:

Fortune Business Insights offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.

Contact Us

Fortune Business Insights Pvt. Ltd.

308, Supreme Headquarters,

Survey No. 36, Baner,

Pune-Bangalore Highway,

Pune – 411045, Maharashtra, India.

Phone:

US: +1 424 253 0390

UK: +44 2071 939123

APAC: +91 744 740 1245

Email: [email protected]